-
-
-
-
-
-
-
Illumina reports preliminary Q4 revenue of $1.16 billion, up 5%
-
-
-
-
-
-
-
Illumina (ILMN) Tops Q3 EPS by 17c; offers guidance
-
-
-
-
-
-
-
Citi names 3 stocks as its new top picks in the Life Science sector
-
-
-
-
-
-
-
Illumina (ILMN) addresses recent developments in China, updates guidance
-
-
-
-
-
-
-
Morgan Stanley sees continued risk for this biotech stock
-
-
-
-
-
-
-
Citi Downgrades Illumina (ILMN) to Neutral
-
-
-
-
-
-
-
TD Cowen Upgrades Illumina (ILMN) to Buy
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

